Summary
The present studies were undertaken to ascertain whether or not an alteration in the availability of serotonin (5 HT) can modify central noradrenergic function at the level of the noradrenaline (NA) receptor coupled adenylate cyclase system in brain. The chronic but not acute administration of the 5HT uptake inhibitors amitriptyline and chlorimipramine reduced the sensitivity of the cyclic AMP generating system to NA in the limbic forebrain. This subsensitivity was linked to a decrease in the B max value of β-adrenergic binding sites without appreciable changes in the K d values, as assessed by specific 3H-dihydroalprenolol binding. The specific 5HT uptake inhibitor fluoxetine did not change either the responsiveness of the cyclic AMP generating system to NA or the density of β-adrenergic receptor sites. Raphé lesions which selectively reduced the level of 5HT also did not cause any changes in the neurohormonal responsiveness or the density of β-adrenergic receptor sites. In contrast, medial forebrain bundle lesions which reduced the levels of both 5HT and catecholamines (NA and dopamine) in the forebrain, increased the responsiveness of the cyclic AMP generating system to NA. It can thus be concluded that a selective change in the availability of 5HT per se does not modify noradrenergic receptor function at the level of the NA receptor coupled adenylate cyclase system. The subsensitivity of the noradrenergic receptor system developed following amitriptyline and chlorimipramine may in all likelihood be due to the in vivo conversion to the secondary amines, nortriptyline and desmethylchlorimipramine respectively. These secondary amine metabolites are potent inhibitors of the NA reuptake and consequently could be responsible for the demonstrated in vivo down-regulation of central adrenergic receptor function (homospecific down-regulation).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Banerjee SP, Kung LS, Riggi SJ, Chande SK (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455–456
Bergstrom DA, Kellar KJ (1979a) Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature 278:464–466
Bergstrom DA, Kellar KJ (1979b) Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther 209:256–261
Blumberg JB, Vetulani J, Stawarz RF, Sulser F (1976) The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization and possible role in the mode of action of antipsychotics. Eur J Pharmacol 37:357–366
Brodie BB, Shore PA (1957) A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann NY Acad Sci 66:631–642
Bylund DB, Snyder SH (1976) Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580
Carlsson A (1976) The contribution of drug research to investigating the nature of endogenous depression. Pharmakopsychiatr Neuropsychopharmacol 9:2–10
Clements-Jewery S (1978) The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine. Neuropharmacology 17:779–781
Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39:653–655
Dismukes RK, Ghosh P, Creveling CR, Daly JW (1975) Altered responsiveness of adenosine 3′,5′-monophosphate generating systems in rat cortical slices after lesions of the median forebrain bundle. Exp Neurol 49:725–735
Frazer A, Hess ME, Mendels J, Gable B, Kunkel E, Bender A (1978) Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects of the rat. J Pharmacol Exp Ther 206:311–319
Fuller RW, Snoddy DH, Perry KW, Bymaster FP, Wong DT (1978) Importance of duration of drug action in the antagonism of pchloroamphetamine depletion of brain serotonin — comparison of fluoxetine and chlorimipramine. Biochem Pharmacol 27:193–198
Gillespie DD, Manier DH, Sulser F (1979) Electroconvulsive treatment: Rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down-regulation of β-adrenergic receptors. Commun Psychopharmacol 3:191–195
Gilman AG (1970) A protein binding assay for adenosine 3′,5′ cyclic monophosphate. Proc Nat Acad Sci (USA) 67:305–312
Kellar KJ, Cascio CS, Butler JA, Kurtzlle RN (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin2 receptors in brain. Eur J Pharmacol 69:515–518
Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of the rat brain. J Pharmacol Exp Ther 199:649–661
König JFP, Klippel RA (1963) The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. R. E. Krieger Publishing Co., Inc., Huntington, NY
Laverty R, Taylor KM (1968) The fluorometric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole technique. Anal Biochem 22:269–279
Lowry DH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Mishra R, Sulser F (1978) Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system. Commun Psychopharmacol 2:365–370
Mishra R, Janowsky A, Sulser F (1979) Subsensitivity of the NE receptor coupled adenylate cyclase system in brain: Effects of nisoxetine vs. fluoxetine. Eur J Pharmacol 60:379–382
Mishra R, Janowsky A, Sulser F (1980) Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding. Neuropharmacology 19:983–987
Peroutka SJ, Snyder SH (1980) Chronic antidepressant treatment lowers spiroperidol-labeled serotonin receptor binding. Science 210:88–90
Perry KW (1980) Assay of biogenic amines and their metabolites in rat brain by LCEC. Symposium sponsored by Bioanalytical systems, Inc., Indianapolis, IN (Abstract) (unpublished)
Robinson SE, Mobley PL, Smith HE, Sulser F (1978) Further characterization of the noradrenergic cyclic AMP generating system in the rat limbic forebrain: Structural and steric requirements for agonists. Naunyn-Schmiedeberg's Arch Pharmacol 303:175–180
Samanin R, Garattini S (1975) The serotonergic system in the brain and its possible functional connections with other aminergic systems. Life Sci 17:1201–1210
Sarai K, Frazer A, Brunswick D, Mendels J (1978) Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex. Biochem Pharmacol 27:2179–2181
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Schmidt MJ, Thornberry JF (1977) Norepinephrine stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine uptake inhibitors. Arch Int Pharmacodyn 229:41–51
Schultz J (1976) Psychoactive drug effects on a system which generates cyclic AMP in brain. Nature 261:417–418
Stein L, Wise CD (1974) Serotonin and behavioral inhibition. Adv Biochem Psychopharmacol 11:281–291
Stone EA (1979) Reduction by stress of norepinephrine stimulated accumulation of cyclic AMP in rat cerebral cortex. J Neurochem 32:1335–1337
Sulser F (1978) Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: Molecular approaches to an understanding of affective disorders. Pharmakopsychiatr 11:43–52
Sulser F (1979) New perspectives on the mode of action of antidepressant drugs. Trends Pharmacol Sci 1:92–94
Sulser F, Mobley PL (1981) Regulation of central noradrenergic receptor function: New vistas on the mode of action of antidepressant treatments. In: Usdin E, Davis JM, Bunney WE (eds) Neuroreceptors: Basic and clinical aspects. Wiley and Sons, Ltd., London (in press)
Tang SW, Helmeste DM, Stancer HC (1978) The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3-methoxy-4-hydroxyphenylglycol. Naunyn-Schmiedeberg's Arch Pharmacol 305:207–211
Thomas PC, Jones RB (1977) The effect of clomipramine and desmethylclomipramine on the in vitro uptake of radiolabelled 5 HT and noradrenaline into rat brain cortical slices. J Pharm Pharmacol 29:562–563
Vetulani J, Sulser F (1975) Action of various antidepressant treatment reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain. Nature 257:495–496
Vetulani J, Stawarz RJ, Dingell JV, Sulser F (1976a) Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: Adaptation to persistant changes in the availability of norepinephrine. J Neurochem 27:661–666
Vetulani J, Stawarz RJ, Dingell JV, Sulser F (1976b) A possible common mechanism of action of antidepressant treatments. Reduction in the sensitivity of the noradrenergic cyclic AMP generating system in the rat limbic forebrain. Naunyn-Schmiedeberg's Arch Pharmacol 293:109–114
Wolfe BB, Harden TK, Sporn JR, Molinoff PB (1978) Presynaptic modulation of β-adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446–457
Wong DT, Bymaster FP, Horng FS, Molloy BB (1975) A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 193:804–811
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mishra, R., Leith, N.J., Steranka, L. et al. The noradrenaline receptor coupled adenylate cyclase system in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 316, 218–224 (1981). https://doi.org/10.1007/BF00505652
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505652